Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel antibody platform called the Adaptive Multi-Epitope Targeting and Avidity-Enhanced (AMETA) Nanobody Platform, designed to counteract viral...
Currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries. A new type of...